These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5927755)

  • 1. Using a mathematical model in the evaluation of human tumor response to chemotherapy.
    Priore RL
    J Natl Cancer Inst; 1966 Nov; 37(5):635-47. PubMed ID: 5927755
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polychemotherapy of malignant neoplasms].
    Kühböck J
    Wien Z Inn Med; 1972; 53(11):553-7. PubMed ID: 4566665
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radio-chemotherapeutic treatment in advanced cases of breast neoplasms].
    Guix Melcior JR
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):807. PubMed ID: 5591689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiblastic effect of various chemotherapeutic preparations on the cells of the Ehrlich ascites tumor].
    Papoian SA; Kumkumadzhian VA
    Vopr Onkol; 1966 Apr; 12(4):56-61. PubMed ID: 6001002
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy of neoplasms].
    Osswald H
    Hippokrates; 1967 Jul; 38(13):497-506. PubMed ID: 5611578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of polychemotherapy of inoperable bronchopulmonary cancers].
    Lemenager J; Foubert C; Neel JP
    Poumon Coeur; 1968; 24(1):77-81. PubMed ID: 5652208
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer chemotherapy today and tomorrow. (A review).
    Shetty PA
    Indian J Cancer; 1971 Mar; 8(1):72-5. PubMed ID: 4934495
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
    Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attack treatment of broncho-pleuro-pulmonary cancer by polychemotherapy under the protection of phytohemagglutinin].
    Brocard H; Akoun G; Turpin G; Gendre JP
    Bull Mem Soc Med Hop Paris; 1967 Jan; 118(2):139-56. PubMed ID: 6061578
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer chemotherapy--a nursing model.
    Levine ME
    Nurs Clin North Am; 1978 Jun; 13(2):271-80. PubMed ID: 248743
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoxydin. (Preliminary report on clinical evaluation).
    Kolár V; Mechl Z
    Neoplasma; 1971; 18(5):485-7. PubMed ID: 5119523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cyclophosphamide and 5-fluoracil in the treatment of inoperable tumors].
    Engell HC; Ulrich K
    Ugeskr Laeger; 1966 Mar; 128(11):325-9. PubMed ID: 5915749
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present and future of tumor chemotherapy].
    Eckhardt S
    Orv Hetil; 1981 Dec; 122(52):3187-90. PubMed ID: 7329693
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive tests for the response to cancer chemotherapy: limitations related to the prediction of rare events.
    Rozencweig M; Staquet M
    Cancer Treat Rep; 1984 Apr; 68(4):611-3. PubMed ID: 6713417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase inhibitors.
    Ackland SP; Clarke SJ; Beale P; Peters GJ
    Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of colorectal cancers: evaluation].
    Pouillart P
    Ann Gastroenterol Hepatol (Paris); 1993 May; 29(3):133-6. PubMed ID: 8517630
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
    Heise C; Lemmon M; Kirn D
    Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in the dihydropyrimidine dehydrogenase expression may contribute to higher toxicity in women treated with 5-fluorouracil therapy.
    Altundag O; Altundag K; Silay K; Turen S
    Med Hypotheses; 2005; 65(6):1196. PubMed ID: 15951130
    [No Abstract]   [Full Text] [Related]  

  • 20. A model system for examining the action of anti-cancer agents at the cellular level in vivo.
    Bruce WR
    Natl Cancer Inst Monogr; 1967 Feb; 24():249-56. PubMed ID: 6021079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.